When was Boehringer Ingelheim founded?

Boehringer Ingelheim was founded on 30 Nov 1988, making it 37 years old.

Is Boehringer Ingelheim still active?

Yes, Boehringer Ingelheim is currently active.

Where is Boehringer Ingelheim registered?

Boehringer Ingelheim's registered address is Avenue Arnaud Fraiteur 15/23, 1050 Ixelles, Belgium.

How many employees does Boehringer Ingelheim have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), Boehringer Ingelheim reported 109.2 full-time equivalent employees.

What is Boehringer Ingelheim's annual turnover?

Boehringer Ingelheim's most recently filed annual turnover (fiscal year ending 31 Dec 2025) was €164,690,516.

Did Boehringer Ingelheim make a profit or a loss?

Boehringer Ingelheim's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a profit of €42,963,439.

When did Boehringer Ingelheim last file annual accounts?

Boehringer Ingelheim's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

Is Boehringer Ingelheim B Corp certified?

We have no B Corp certification on file for Boehringer Ingelheim.

Does Boehringer Ingelheim hold Fairtrade certification?

No, Boehringer Ingelheim does not currently hold Fairtrade certification.

Boehringer Ingelheim

Q: What does Boehringer Ingelheim do?

Boehringer Ingelheim's registered main activities are Activities of head offices, Wholesale of pharmaceutical and medical goods, Research and experimental development on other natural sciences and engineering, Market research and public opinion polling, Activities of holding companies, Other cargo handling except in ports, Manufacture of medicaments, Design and realisation of advertising campaigns for third parties, using all media, Office administrative and support activities, and Other business support service activities n.e.c.. It is also registered for 1 additional activity.

BE 0435.953.632

Copied!

CommV/SComm

Status

Active

Founded

30 Nov 1988 · 37 yrs

Size

Large · 109.2 FTE

Legal name

Boehringer Ingelheim SComm

Main activity

Activities of head offices

Website

boehringer-ingelheim.be

Activities

11 activities

Activities of head officesWholesale of pharmaceutical and medical goodsResearch and experimental development on other natural sciences and engineeringMarket research and public opinion pollingActivities of holding companiesOther cargo handling except in portsManufacture of medicamentsDesign and realisation of advertising campaigns for third parties, using all mediaOffice administrative and support activitiesOther business support service activities n.e.c.Other credit granting n.e.c.

Financials

Turnover2025

€165M+8.9%

Profit / Loss2025

€43M-0.2%

Equity2025

€1.5B+95.2%

2025	2024	2023	2022
€164,690,516+8.9%	€151,189,930+16.9%	€129,328,487+15%	€112,415,839
€42,963,439-0.2%	€43,063,767+83.5%	€23,469,158+440.7%	-€6,889,204
€1,537,702,789+95.2%	€787,702,7890%	€787,702,789+0.3%	€785,444,514
€56,281,526-92.7%	€771,185,955+32.4%	€582,673,302-2.1%	€595,323,928
€191,292-62.2%	€506,003+419.9%	€97,335+295.8%	€24,591
109.2-2.4%	111.9+1.5%	110.3-8.5%	120.5
€1,508,155+11.6%	€1,351,116+15.2%	€1,172,516+25.7%	€932,912

Frequently asked questions

01What is Boehringer Ingelheim's official registered name?

Boehringer Ingelheim SComm.

02What is Boehringer Ingelheim's enterprise number (VAT number)?

BE 0435.953.632.

03What is Boehringer Ingelheim's legal form?

Commanditaire vennootschap (CommV) / Société en commandite (SComm).

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2025	2024	2023	2022
Income statement
	€164,690,516+8.9%	€151,189,930+16.9%	€129,328,487+15%	€112,415,839
	€19,273,390+3.2%	€18,670,105-0.2%	€18,709,337+7%	€17,480,188
	€8,387,452-58%	€19,981,465+217%	€6,302,644+169.6%	-€9,058,186
	€11,041,742-47%	€20,818,280+209.2%	€6,733,508+181.7%	-€8,246,187
	€45,022,030+1%	€44,568,582+88.3%	€23,670,451+599.9%	-€4,735,378
	€42,963,439-0.2%	€43,063,767+83.5%	€23,469,158+440.7%	-€6,889,204
	€1,836,954+43.6%	€1,279,271-49.3%	€2,522,308>1000%	€80,392
Profitability
	6.7%-51.3%	13.8%+164.5%	5.2%+171%	-7.3%
	26.1%-8.4%	28.5%+57%	18.1%+396.1%	-6.1%
	2.8%-48.9%	5.5%+83.5%	3.0%+439.7%	-0.9%
	2.7%-2.3%	2.8%+62.9%	1.7%+443.3%	-0.5%
Solvency
	€1,598,357,664+2.1%	€1,565,522,514+12.7%	€1,389,677,141-0.8%	€1,400,299,062
	€857,705-22.2%	€1,103,094-18.9%	€1,360,377+1.4%	€1,341,505
	€1,537,702,789+95.2%	€787,702,7890%	€787,702,789+0.3%	€785,444,514
	96.2%+91.2%	50.3%-11.2%	56.7%+1.1%	56.1%
	€56,281,526-92.7%	€771,185,955+32.4%	€582,673,302-2.1%	€595,323,928
	0.04-96.3%	0.98+32.4%	0.74-2.4%	0.76
	3.32+399.8%	0.67+117%	0.31+110.8%	-2.85
Liquidity
	€191,292-62.2%	€506,003+419.9%	€97,335+295.8%	€24,591
	€23,220,609+0.6%	€23,088,573-8.6%	€25,254,208+29%	€19,575,181
	€24,974,852+13.2%	€22,061,298+18.8%	€18,577,556+5.7%	€17,568,930
	€23,694,981-6.1%	€25,243,654+4.6%	€24,124,373+5.7%	€22,833,252
	€44,242,690-94.2%	€760,019,662+32.1%	€575,198,616-1.9%	€586,309,105
	28.38>1000%	2.03-14.9%	2.38+1.4%	2.35
	€1,541,218,434+94.3%	€793,233,466-1.5%	€805,643,461+0.3%	€803,633,630
Efficiency
	55 days+3.9%	53 days+1.6%	52 days-8.1%	57 days
	88 days-8.8%	96 days-7.9%	105 days-6.8%	112 days
	110 days-2.6%	112 days-18.7%	138 days+9.8%	126 days
	3.34+7.7%	3.10+4.4%	2.97-9.2%	3.27
Profit appropriation
	€42,963,439-0.2%	€43,063,767+103%	€21,210,883>1000%	€1,260,844
	€92,0570%	€92,0570%	€92,057-99%	€9,122,470
	€4,912,2150%	€4,912,2150%	€4,912,215+177%	-€6,376,473

Sources

NBB — Nationale Bank van België

	2025	2024	2023	2022
Income statement
	€164,690,516+8.9%	€151,189,930+16.9%	€129,328,487+15%	€112,415,839
	€19,273,390+3.2%	€18,670,105-0.2%	€18,709,337+7%	€17,480,188
	€8,387,452-58%	€19,981,465+217%	€6,302,644+169.6%	-€9,058,186
	€11,041,742-47%	€20,818,280+209.2%	€6,733,508+181.7%	-€8,246,187
	€45,022,030+1%	€44,568,582+88.3%	€23,670,451+599.9%	-€4,735,378
	€42,963,439-0.2%	€43,063,767+83.5%	€23,469,158+440.7%	-€6,889,204
	€1,836,954+43.6%	€1,279,271-49.3%	€2,522,308>1000%	€80,392
Profitability
	6.7%-51.3%	13.8%+164.5%	5.2%+171%	-7.3%
	26.1%-8.4%	28.5%+57%	18.1%+396.1%	-6.1%
	2.8%-48.9%	5.5%+83.5%	3.0%+439.7%	-0.9%
	2.7%-2.3%	2.8%+62.9%	1.7%+443.3%	-0.5%
Solvency
	€1,598,357,664+2.1%	€1,565,522,514+12.7%	€1,389,677,141-0.8%	€1,400,299,062
	€857,705-22.2%	€1,103,094-18.9%	€1,360,377+1.4%	€1,341,505
	€1,537,702,789+95.2%	€787,702,7890%	€787,702,789+0.3%	€785,444,514
	96.2%+91.2%	50.3%-11.2%	56.7%+1.1%	56.1%
	€56,281,526-92.7%	€771,185,955+32.4%	€582,673,302-2.1%	€595,323,928
	0.04-96.3%	0.98+32.4%	0.74-2.4%	0.76
	3.32+399.8%	0.67+117%	0.31+110.8%	-2.85
Liquidity
	€191,292-62.2%	€506,003+419.9%	€97,335+295.8%	€24,591
	€23,220,609+0.6%	€23,088,573-8.6%	€25,254,208+29%	€19,575,181
	€24,974,852+13.2%	€22,061,298+18.8%	€18,577,556+5.7%	€17,568,930
	€23,694,981-6.1%	€25,243,654+4.6%	€24,124,373+5.7%	€22,833,252
	€44,242,690-94.2%	€760,019,662+32.1%	€575,198,616-1.9%	€586,309,105
	28.38>1000%	2.03-14.9%	2.38+1.4%	2.35
	€1,541,218,434+94.3%	€793,233,466-1.5%	€805,643,461+0.3%	€803,633,630
Efficiency
	55 days+3.9%	53 days+1.6%	52 days-8.1%	57 days
	88 days-8.8%	96 days-7.9%	105 days-6.8%	112 days
	110 days-2.6%	112 days-18.7%	138 days+9.8%	126 days
	3.34+7.7%	3.10+4.4%	2.97-9.2%	3.27
Profit appropriation
	€42,963,439-0.2%	€43,063,767+103%	€21,210,883>1000%	€1,260,844
	€92,0570%	€92,0570%	€92,057-99%	€9,122,470
	€4,912,2150%	€4,912,2150%	€4,912,215+177%	-€6,376,473

2025

2024

2023

2022

Income statement

€164,690,516+8.9%

€151,189,930+16.9%

€129,328,487+15%

€112,415,839

€19,273,390+3.2%

€18,670,105-0.2%

€18,709,337+7%

€17,480,188

€8,387,452-58%

€19,981,465+217%

€6,302,644+169.6%

-€9,058,186

€11,041,742-47%

€20,818,280+209.2%

€6,733,508+181.7%

-€8,246,187

€45,022,030+1%

€44,568,582+88.3%

€23,670,451+599.9%

-€4,735,378

€42,963,439-0.2%

€43,063,767+83.5%

€23,469,158+440.7%

-€6,889,204

€1,836,954+43.6%

€1,279,271-49.3%

€2,522,308>1000%

€80,392

Profitability

6.7%-51.3%

13.8%+164.5%

5.2%+171%

-7.3%

26.1%-8.4%

28.5%+57%

18.1%+396.1%

-6.1%

2.8%-48.9%

5.5%+83.5%

3.0%+439.7%

-0.9%

2.7%-2.3%

2.8%+62.9%

1.7%+443.3%

-0.5%

Solvency

€1,598,357,664+2.1%

€1,565,522,514+12.7%

€1,389,677,141-0.8%

€1,400,299,062

€857,705-22.2%

€1,103,094-18.9%

€1,360,377+1.4%

€1,341,505

€1,537,702,789+95.2%

€787,702,7890%

€787,702,789+0.3%

€785,444,514

96.2%+91.2%

50.3%-11.2%

56.7%+1.1%

56.1%

€56,281,526-92.7%

€771,185,955+32.4%

€582,673,302-2.1%

€595,323,928

0.04-96.3%

0.98+32.4%

0.74-2.4%

0.76

3.32+399.8%

0.67+117%

0.31+110.8%

-2.85

Liquidity

€191,292-62.2%

€506,003+419.9%

€97,335+295.8%

€24,591

€23,220,609+0.6%

€23,088,573-8.6%

€25,254,208+29%

€19,575,181

€24,974,852+13.2%

€22,061,298+18.8%

€18,577,556+5.7%

€17,568,930

€23,694,981-6.1%

€25,243,654+4.6%

€24,124,373+5.7%

€22,833,252

€44,242,690-94.2%

€760,019,662+32.1%

€575,198,616-1.9%

€586,309,105

28.38>1000%

2.03-14.9%

2.38+1.4%

2.35

€1,541,218,434+94.3%

€793,233,466-1.5%

€805,643,461+0.3%

€803,633,630

Efficiency

55 days+3.9%

53 days+1.6%

52 days-8.1%

57 days

88 days-8.8%

96 days-7.9%

105 days-6.8%

112 days

110 days-2.6%

112 days-18.7%

138 days+9.8%

126 days

3.34+7.7%

3.10+4.4%

2.97-9.2%

3.27

Profit appropriation

€42,963,439-0.2%

€43,063,767+103%

€21,210,883>1000%

€1,260,844

€92,0570%

€92,057-99%

€9,122,470

€4,912,2150%

€4,912,215+177%

-€6,376,473

Boehringer Ingelheim

Activities

Financials

Frequently asked questions

All locations

All locations